scholarly journals Complete Genome Sequence of Achromobacter xylosoxidans Myophage Mano

2021 ◽  
Vol 10 (2) ◽  
Author(s):  
Mariah Bartz ◽  
Guichun Yao ◽  
Tram Le ◽  
Mei Liu ◽  
Ben Burrowes ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Respiratory Tract ◽  
Genome Sequence ◽  
Respiratory Tract Infections ◽  
Achromobacter Xylosoxidans ◽  
Gram Negative Bacteria ◽  
Biotechnological Potential ◽  
Gram Negative ◽  
Content Type ◽  
Tract Infections

ABSTRACT Achromobacter spp. are ubiquitous Gram-negative bacteria, some of which can cause respiratory tract infections in patients with autoimmune disorders and cystic fibrosis. Bacteriophages have therapeutic and biotechnological potential to combat Achromobacter sp. infections. This announcement details the 42.5-kb genome sequence of the temperate Achromobacter xylosoxidans myophage Mano.

scholarly journals Complete Genome Sequence of Burkholderia gladioli Myophage Mana

2021 ◽  
Vol 10 (20) ◽  
Author(s):  
Brenda Godoy ◽  
Guichun Yao ◽  
Tram Le ◽  
Maria Guadalupe Vizoso-Pinto ◽  
Jason Gill ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Respiratory Tract ◽  
Genome Sequence ◽  
Complete Genome Sequence ◽  
Complete Genome ◽  
Respiratory Tract Infections ◽  
Phage Therapy ◽  
Content Type ◽  
Burkholderia Gladioli ◽  
Tract Infections

ABSTRACT Burkholderia gladioli is known to cause respiratory tract infections in cystic fibrosis patients. Here, we describe the annotation of the 38,038-bp genome sequence of Mana, a P2-like phage of B. gladioli. Understanding the genomic characteristics of phages infecting pathogens like B. gladioli can lead to advancements in phage therapy.

scholarly journals Phenotypic and genotypic characterization of plasmid-mediated AmpC beta-lactamases in enteric Gram-negative bacteria from patients with lower respiratory tract infections in a tertiary hospital, southwest Nigeria

2021 ◽  
Vol 22 (4) ◽  
pp. 465-472
Author(s):  
O.A. Thonda ◽  
A.O. Oluduro ◽  
O.O. Adewole ◽  
P.O. Obiajunwa
Keyword(s):  
Antibiotic Resistance ◽  
Respiratory Tract ◽  
Lower Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Gram Negative Bacteria ◽  
Lower Respiratory Tract Infections ◽  
Gram Negative ◽  
Beta Lactamases ◽  
Tract Infections ◽  
High Degree

Background: AmpC or class C or group 1 beta lactamases are class C cephalosporinases that hydrolyse a wide variety of beta-lactam antibiotics including alpha methoxy beta-lactams (cefoxitin), narrow and broad spectrum cephalosporins. This study was conducted to characterize plasmid-mediated AmpC producing enteric Gram- negative bacteria from patients with lower respiratory tract infections in Obafemi Awolowo University Teaching Hospital Complex (OAUTHC) Ile Ife, Osun State, NigeriaMethodology: A total of 149 patients with clinical features of lower respiratory tract infections (LRTI) were selected by simple random sampling for the study. All Gram-negative isolates recovered from standard microbiological cultures of respiratory specimens of these patients were tested against cefoxitin, third generation cephalosporins (3GCs), and other antibiotics using the disc diffusion AST method, and also screened for production of AmpC beta-lactamases phenotypically by the CLSI method. Plasmid DNA extraction was carried out on twenty-nine cefoxitin-resistant selected isolates using the Kado and Lin method, while genotypic detection of plasmid-mediated AmpC gene was carried out by the polymerase chain reaction (PCR) assay.Results: The results showed that 204 (43.3%) of 471 isolates recovered from the 149 selected patients were resistant to 3GC in the AST assay, among which 121 (59.3%) were resistant to cefoxitin, and 189 of the 471 isolates (40.1%) were AmpC producers. The AmpC producers concurrently showed multiple resistance pattern to other antibiotics tested in this study. Ninety six percent of the 29 selected isolates for plasmid analysis contained plasmids, 45% of which amplified positive on PCR for CMY, 38% for FOX, and 31% for ACC types of AmpC genes.Conclusion: This study showed a high degree of antibiotic resistance among enteric Gram-negative bacteria recovered from patients with LRTIs, as well as high degree of plasmid-encoded AmpC genes responsible for this high antibiotic resistance among the isolates. Proper antibiotic policy and regulation are required to limit the spread of plasmid mediated AmpC β-lactamase producing organisms because they can lead to therapeutic failure in infected patients in the nearest future.   French title: Caractérisation phénotypique et génotypique des bêta-lactamases AmpC à médiation plasmidique dans les bactéries entériques Gram-négatives de patients atteints d'infections des voies respiratoires inférieures dans un hôpital tertiaire, sud-ouest du Nigéria Contexte: Les bêta-lactamases AmpC ou de classe C ou de groupe 1 sont des céphalosporinases de classe C qui hydrolysent une grande variété d'antibiotiques bêta-lactamines, y compris les alpha-méthoxy bêta-lactamines (céfoxitine), les céphalosporines à spectre étroit et large. Cette étude a été menée pour caractériser les bactéries à Gram négatif entériques produisant de l'AmpC à médiation plasmidique chez des patients atteints d'infections des voies respiratoires inférieures du complexe hospitalier universitaire d'Obafemi Awolowo (OAUTHC) Ile Ife, État d'Osun, NigériaMéthodologie: Un total de 149 patients présentant des caractéristiques cliniques d'infections des voies respiratoires inférieures (LRTI) ont été sélectionnés par échantillonnage aléatoire simple pour l'étude. Tous les isolats à Gram négatif récupérés à partir de cultures microbiologique standard d'échantillons respiratoires de ces patients ont été testés contre la céfoxitine, les céphalosporines de troisième génération (3GC) et d'autres antibiotiques en utilisant la méthode AST de diffusion sur disque, et également criblés pour la production de bêtalactamases AmpC phénotypiquement par le Méthode CLSI. L'extraction de l'ADN plasmidique a été réalisée sur 29 isolats sélectionnés résistants à la céfoxitine en utilisant la méthode Kado et Lin, tandis que la détection  génotypique du gène AmpC à médiation plasmidique a été réalisée par le test de réaction en chaîne par polymérase (PCR).Résultats: Les résultats ont montré que 204 (43,3%) des 471 isolats récupérés des 149 patients sélectionnés étaient résistants à la 3GC dans le test AST, parmi lesquels 121 (59,3%) étaient résistants à la céfoxitine et 189 des 471 isolats (40,1%) étaient des producteurs d'AmpC. Les producteurs d'AmpC ont montré simultanément plusieurs profils de résistance à d'autres antibiotiques testés dans cette étude. Quatre-vingt-seize pour cent des 29 isolats sélectionnés pour l'analyse des plasmides contenaient des plasmides, dont 45%  amplifiés positifs par PCR pour CMY, 38% pour FOX et 31% pour les types ACC des gènes AmpC.Conclusion: Cette étude a montré un degré élevé de résistance aux antibiotiques parmi les bactéries entériques Gram-négatives  récupérées chez des patients atteints de LRTI, ainsi qu'un degré élevé de gènes AmpC codés par plasmide responsable de cette résistance élevée aux antibiotiques parmi les isolats. Une politique et une réglementation appropriées en matière d'antibiotiques sont nécessaires pour limiter la propagation des organismes producteurs β-lactamase d'AmpC à médiation plasmidique car ils peuvent conduire à un échec thérapeutique chez les patients infectés dans un avenir proche.  

scholarly journals Current Trend in the Antibiogram of Bacterial Pathogens of Adult Lower Respiratory Tract Infections in a Nigerian Tertiary Hospital

2021 ◽  
pp. 10-18
Author(s):  
Oluwalana T. Oyekale ◽  
Bola O. Ojo ◽  
Damilola E. Oguntunmbi ◽  
Oluwatoyin I. Oyekale
Keyword(s):  
Respiratory Tract ◽  
Antibiotic Susceptibility ◽  
Lower Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Bacterial Pathogens ◽  
Empirical Treatment ◽  
Gram Negative Bacteria ◽  
Lower Respiratory Tract Infections ◽  
Gram Negative ◽  
Tract Infections

Background: Lower respiratory tract infections (LRTIs) are among the commonest infectious diseases requiring hospitalization. There is an increasing resistance development of bacterial pathogens of LRTIs to the commonly prescribed antibiotics necessitating regular surveillance for these bacteria and their antibiogram. Aim: To identify bacterial pathogens of adult LRTIs, determine their antibiotic susceptibility pattern, and suggest the best empirical treatment of adult LRTIs in the setting. Study Design: Descriptive cross-sectional study. Methods: A total of 194 respiratory samples from 194 consecutive consenting adult in-patient of a Federal Teaching Hospital were processed. Identification of isolated bacteria and antibiotic susceptibility testing of the isolates were carried out following the standard protocol. Results: Bacteria isolation was seen in 52.1% of all specimens, highest isolation rate was from sputum (55.2%). Isolation was higher in males (54.9%) than females (48.1%) but no significant difference was seen (P=0.36). Gram negative bacteria were predominantly isolated (64.4%) and Klebsilla pneumoniae was the most common (33.7%). Eight extended-spectrum beta-lactamase (ESBL) producers and 3 methicillin-resistant Staphylococcus aureus (MRSA) were also detected. All isolates were sensitive to imipenem and meropenem. All MRSAs were sensitive to vancomycin. There was poor sensitivity pattern seen against most antibiotics tested. Conclusion: Gram negative bacteria were the predominant bacterial pathogen isolated, and isolates were resistant to most antibiotics tested, though, all were sensitive to carbapenems. Levofloxacin plus gentamicin, and carbapenems were the suggested first and second line empirical treatment of choice respectively for adult LRTIs in this and similar settings.

scholarly journals Comparative characteristics and clinical presentation of cystic fibrosis in adults with chronic lower respiratory tract infections with Pseudomonas aeruginosa and other non-fermenting gram-negative bacilli

2020 ◽  
Vol 4 (4) ◽  
pp. 186-191
Author(s):  
V.R. Makhmutova ◽  
◽  
T.E. Gembitskaya ◽  
A.G. Chermenskiy ◽  
O.N. Titova ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Respiratory Tract ◽  
Burkholderia Cepacia ◽  
Lower Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Lower Respiratory Tract Infections ◽  
Gram Negative ◽  
Pseudomonas Infection ◽  
Tract Infections

Background: in Russia, the life expectancy of cystic fibrosis (CF) patients increased by 10 years in 2011–2017 being 55.49 years in 2017. However, the number of patients with the chronic infection caused by non-fermenting gram-negative bacilli (NFGNB), e.g., Burkholderia cepacia, Achromobacter spp. etc., increased as well. Aim: to evaluate the differences in the nutritional and functional status and the severity of mutations in CF patients with chronic Pseudomonas infection or NFGNB infection and to assess the sensitivity of P. aeruginosa to tobramycin in CF patients in the Northwest region of Russia. Patients and Methods: 31 patients with CF aged 18–43 years (18 men and 13 women) were examined. The duration of the study was 12 months. Spirometry, anthropometry, and sputum culture were performed. Results: P. aeruginosa alone was isolated in 18 patients (58%), Achromobacter spp. in 9 patients (29%), and Burkholderia spp. in 4 patients (13%). The patients were divided into two groups, i.e., patients with chronic Pseudomonas infection (group 1, n=18, 10 out of 18 patients with mucoid strains of P. aeruginosa) or chronic NFGNB infection (group 2, n=13). The median age and the mode age were 27 years and 27 years, respectively, in group 1 and 24 years and 22 years, respectively, in group 2. It was demonstrated that CF patients with chronic NFGNB infection are characterized by poorer nutritional status (p<0.05) but similar functional status and the severity of CFTR gene mutation compared to CF patients with chronic Pseudomonas infection. It was also shown that Р. aeruginosa is highly sensitive to tobramycin (94.4%). Conclusions: in CF patients, chronic lower respiratory tract infections with Burkholderia cepacia and Achromobacter spp. account for 41.9% of gram-negative rod infections. Further studies and drug sensitivity monitoring are needed. KEYWORDS: cystic fibrosis, DNA test, chronic infection with Pseudomonas aeruginosa, Burkholderia cepacia, Achromobacter spp, non-fermenting gram-negative bacilli, CFTR mutation, nutritional status, pulmonary function tests, inhaled antibiotic therapy. FOR CITATION: Makhmutova V.R., Gembitskaya T.E., Chermenskiy A.G. et al. Comparative characteristics and clinical presentation of cystic fibrosis in adults with chronic lower respiratory tract infections with Pseudomonas aeruginosa and other non-fermenting gram-negative bacilli. Russian Medical Inquiry. 2020;4(4):186–191. DOI: 10.32364/2587-6821-2020-4-4-186-191.

Amikacin in Gram-Negative Paediatric Infections

1978 ◽  
Vol 6 (4) ◽  
pp. 257-265
Author(s):  
Hugo Trujillo ◽  
Rafael Manotas ◽  
Jose Ivan Ramirez ◽  
Alvaro Uribe ◽  
Nancy Agudelo ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Intestinal Tract ◽  
Cure Rate ◽  
Gram Negative ◽  
Complete Cure ◽  
Tract Infections ◽  
Gastro Intestinal Tract

Amikacin was used in the treatment of various Gram-negative infections in sixty-six children ranging in age from two days to thirteen years. Over 72% of the infections treated were classified as severe and the remainder were moderate. Among infections in which the site of origin was the urinary or gastro-intestinal tract, amikacin achieved thirty-eight (95%) complete or partial cures in forty patients. In respiratory tract infections, amikacin completely or partially cured six (75%) out of eight patients. The remaining eighteen infections involved skin, soft tissue and other miscellaneous categories in which amikacin therapy resulted in seventeen (94%) complete or partial cures. Overall, amikacin achieved fifty-four complete cures and seven clinical or bacteriological cures in sixty-six patients, which represents an 82% complete cure rate and 10% partial cure rate for all the patients in the study.

scholarly journals Ritkábban előforduló, alsó légúti fertőzést okozó Gram-negatív nem fermentáló pálcák

2018 ◽  
Vol 159 (1) ◽  
pp. 23-30
Author(s):  
Emese Juhász ◽  
Miklós Iván ◽  
Júlia Pongrácz ◽  
Katalin Kristóf
Keyword(s):  
Respiratory Tract ◽  
Lower Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Diffusion Method ◽  
Lower Respiratory Tract Infections ◽  
Gram Negative ◽  
Maldi Tof Ms ◽  
Maldi Tof ◽  
Tract Infections ◽  
Tof Ms

Abstract: Introduction: Glucose non-fermenting Gram-negative bacteria are ubiquitous environmental organisms. Most of them are identified as opportunistic, nosocomial pathogens in patients. Uncommon species are identified accurately, mainly due to the introduction of matrix-assisted laser desorption-ionization time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology practice. Most of these uncommon non-fermenting rods are isolated from lower respiratory tract samples. Their significance in lower respiratory tract infections, such as rules of their testing are not clarified yet. Aim: The aim of this study was to review the clinical microbiological features of these bacteria, especially their roles in lower respiratory tract infections and antibiotic treatment options. Method: Lower respiratory tract samples of 3589 patients collected in a four-year period (2013–2016) were analyzed retrospectively at Semmelweis University (Budapest, Hungary). Identification of bacteria was performed by MALDI-TOF MS, the antibiotic susceptibility was tested by disk diffusion method. Results: Stenotrophomonas maltophilia was revealed to be the second, whereas Acinetobacter baumannii the third most common non-fermenting rod in lower respiratory tract samples, behind the most common Pseudomonas aeruginosa. The total number of uncommon non-fermenting Gram-negative isolates was 742. Twenty-three percent of isolates were Achromobacter xylosoxidans. Beside Chryseobacterium, Rhizobium, Delftia, Elizabethkingia, Ralstonia and Ochrobactrum species, and few other uncommon species were identified among our isolates. The accurate identification of this species is obligatory, while most of them show intrinsic resistance to aminoglycosides. Resistance to ceftazidime, cefepime, piperacillin-tazobactam and carbapenems was frequently observed also. Conclusions: Ciprofloxacin, levofloxacin and trimethoprim-sulfamethoxazole were found to be the most effective antibiotic agents. Orv Hetil. 2018; 159(1): 23–30.

scholarly journals Complete Genome Sequence of Pseudomonas aeruginosa Strain AA2 (LMG 27630), an Early Isolate Recovered from the Airway of a German Cystic Fibrosis Patient

2020 ◽  
Vol 9 (26) ◽  
Author(s):  
Andrea Sass ◽  
Tom Coenye
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Respiratory Tract ◽  
Cystic Fibrosis Patient ◽  
Genome Sequence ◽  
Complete Genome Sequence ◽  
Opportunistic Pathogen ◽  
Content Type ◽  
Airway Infections ◽  
Early Isolate

ABSTRACT Pseudomonas aeruginosa is an opportunistic pathogen that is able to cause various infections, including airway infections in cystic fibrosis patients. Here, we present the complete closed and annotated genome sequence of P. aeruginosa AA2, an isolate obtained early during infection of the respiratory tract of a German cystic fibrosis patient.

Sign in / Sign up

Export Citation Format

Share Document